Pirfenidone in heart failure with preserved ejection fraction—rationale and design of the PIROUETTE trial
<p><strong>Background</strong></p> <p>The PIROUETTE (PIRfenidOne in patients with heart failUre and preserved lEfT venTricular Ejection fraction) trial is designed to evaluate the efficacy and safety of the anti-fibrotic pirfenidone in patients with chronic heart failur...
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Springer Nature
2019
|